Literature DB >> 31738990

Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study.

Tetsuo Shoda1, Ting Wen1, Julie M Caldwell1, Margaret H Collins2, John A Besse1, Garrett A Osswald1, J Pablo Abonia1, Nicoleta C Arva3, Dan Atkins4, Kelley E Capocelli5, Evan S Dellon6, Gary W Falk7, Nirmala Gonsalves8, Sandeep K Gupta9, Ikuo Hirano8, Vincent A Mukkada10, Philip E Putnam10, Rachel M Sheridan2, Amanda K Rudman Spergel11, Jonathan M Spergel12, Joshua B Wechsler13, Guang-Yu Yang14, Seema S Aceves15, Glenn T Furuta16, Marc E Rothenberg17.   

Abstract

BACKGROUND: Eosinophilic gastritis (EG) is a clinicopathologic disorder with marked gastric eosinophilia and clinical symptoms. There is an unmet need among patients with EG for more precise diagnostic tools.
OBJECTIVE: We aimed to develop tissue- and blood-based diagnostic platforms for EG.
METHODS: Patients with EG and control subjects without EG were enrolled across 9 Consortium of Eosinophilic Gastrointestinal Disease Researchers-associated sites. An EG Diagnostic Panel (EGDP; gastric transcript subset) and EG blood biomarker panel (protein multiplex array) were analyzed. EGDP18 scores were derived from the expression of 18 highly dysregulated genes, and blood EG scores were derived from dysregulated cytokine/chemokine levels.
RESULTS: Gastric biopsy specimens and blood samples from 185 subjects (patients with EG, n = 74; control subjects without EG, n = 111) were analyzed. The EGDP (1) identified patients with active EG (P < .0001, area under the curve ≥ 0.95), (2) effectively monitored disease activity in longitudinal samples (P = .0078), (3) highly correlated in same-patient samples (antrum vs body, r = 0.85, P < .0001), and (4) inversely correlated with gastric peak eosinophil levels (r = -0.83, P < .0001), periglandular circumferential collars (r = -0.73, P < .0001), and endoscopic nodularity (r = -0.45, P < .0001). For blood-based platforms, eotaxin-3, thymus and activation-regulated chemokine, IL-5, and thymic stromal lymphopoietin levels were significantly increased. Blood EG scores (1) distinguished patients with EG from control subjects without EG (P < .0001, area under the curve ≥ 0.91), (2) correlated with gastric eosinophil levels (plasma: r = 0.72, P = .0002; serum: r = 0.54, P = .0015), and (3) inversely correlated with EGDP18 scores (plasma: r = -0.64, P = .0015; serum: r = -0.46, P = .0084). Plasma eotaxin-3 levels strongly associated with gastric CCL26 expression (r = 0.81, P < .0001).
CONCLUSION: We developed tissue- and blood-based platforms for assessment of EG and uncovered robust associations between specific gastric molecular profiles and histologic and endoscopic features, providing insight and clinical readiness tools for this emerging rare disease.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Entities:  

Keywords:  Biomarker; diagnostic panel; eosinophil; eosinophilic gastritis; transcriptome

Mesh:

Substances:

Year:  2019        PMID: 31738990      PMCID: PMC6949389          DOI: 10.1016/j.jaci.2019.11.007

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  28 in total

1.  Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.

Authors:  Julie M Caldwell; Margaret H Collins; Emily M Stucke; Philip E Putnam; James P Franciosi; Jonathan P Kushner; J Pablo Abonia; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2014-09-15       Impact factor: 10.793

2.  Gene Expression Patterns in Distinct Endoscopic Findings for Eosinophilic Gastritis in Children.

Authors:  Masamichi Sato; Tetsuo Shoda; Hirotaka Shimizu; Kanami Orihara; Kyoko Futamura; Akio Matsuda; Yoshiyuki Yamada; Rie Irie; Takako Yoshioka; Toshiaki Shimizu; Yukihiro Ohya; Ichiro Nomura; Kenji Matsumoto; Katsuhiro Arai
Journal:  J Allergy Clin Immunol Pract       Date:  2017-05-16

3.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.

Authors:  Carine Blanchard; Ning Wang; Keith F Stringer; Anil Mishra; Patricia C Fulkerson; J Pablo Abonia; Sean C Jameson; Cassie Kirby; Michael R Konikoff; Margaret H Collins; Mitchell B Cohen; Rachel Akers; Simon P Hogan; Amal H Assa'ad; Philip E Putnam; Bruce J Aronow; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

4.  Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration.

Authors:  Sandeep K Gupta; Gary W Falk; Seema S Aceves; Mirna Chehade; Margaret H Collins; Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; Vincent A Mukkuda; Kathryn A Peterson; Jonathan Spergel; Guang-Yu Yang; Glenn T Furuta; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2018-11-17       Impact factor: 22.682

Review 5.  Eosinophilic gastrointestinal disorders (EGID).

Authors:  Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

6.  Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis.

Authors:  Andres Matoso; Vincent A Mukkada; Shaolei Lu; Renee Monahan; Kelly Cleveland; Lelia Noble; Shamlal Mangray; Murray B Resnick
Journal:  Mod Pathol       Date:  2013-03-15       Impact factor: 7.842

7.  Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.

Authors:  K Polzer; T Karonitsch; T Neumann; G Eger; C Haberler; A Soleiman; B Hellmich; E Csernok; J Distler; B Manger; K Redlich; G Schett; J Zwerina
Journal:  Rheumatology (Oxford)       Date:  2008-04-08       Impact factor: 7.580

8.  RNA sequencing confirms similarities between PPI-responsive oesophageal eosinophilia and eosinophilic oesophagitis.

Authors:  K A Peterson; M Yoshigi; M W Hazel; D A Delker; E Lin; C Krishnamurthy; N Consiglio; J Robson; M Yandell; F Clayton
Journal:  Aliment Pharmacol Ther       Date:  2018-06-04       Impact factor: 8.171

9.  Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment.

Authors:  Alyse Bedell; Tiffany Taft; Meredith R Craven; Livia Guadagnoli; Ikuo Hirano; Nirmala Gonsalves
Journal:  Dig Dis Sci       Date:  2018-02-23       Impact factor: 3.199

10.  Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.

Authors:  Takechiyo Yamada; Yui Miyabe; Shigeharu Ueki; Shigeharu Fujieda; Takahiro Tokunaga; Masafumi Sakashita; Yukinori Kato; Takahiro Ninomiya; Yohei Kawasaki; Shinsuke Suzuki; Hidekazu Saito
Journal:  Front Immunol       Date:  2019-02-04       Impact factor: 7.561

View more
  17 in total

1.  A Gut-Wrenching Case of Hypereosinophilia.

Authors:  Shajitha Melethil; J Pablo Abonia
Journal:  J Allergy Clin Immunol Pract       Date:  2021-09

Review 2.  Eosinophilic Gastritis/Gastroenteritis.

Authors:  Phillip H Chen; Lorraine Anderson; Kuixing Zhang; Guy A Weiss
Journal:  Curr Gastroenterol Rep       Date:  2021-07-30

3.  Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort.

Authors:  Julia L M Dunn; Tetsuo Shoda; Julie M Caldwell; Ting Wen; Seema S Aceves; Margaret H Collins; Evan S Dellon; Gary W Falk; John Leung; Lisa J Martin; Paul Menard-Katcher; Amanda K Rudman-Spergel; Jonathan M Spergel; Joshua B Wechsler; Guang-Yu Yang; Glenn T Furuta; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2020-03-19       Impact factor: 10.793

Review 4.  Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Authors:  Seema Aceves; Margaret H Collins; Marc E Rothenberg; Glenn T Furuta; Nirmala Gonsalves
Journal:  J Allergy Clin Immunol       Date:  2019-11-20       Impact factor: 10.793

Review 5.  Eosinophilic gastrointestinal disease below the belt.

Authors:  Robert D Pesek; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2019-10-24       Impact factor: 10.793

6.  Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab.

Authors:  Evan S Dellon; Nirmala Gonsalves; Marc E Rothenberg; Ikuo Hirano; Mirna Chehade; Kathryn A Peterson; Gary W Falk; Joseph A Murray; Lauren T Gehman; Alan T Chang; Bhupinder Singh; Henrik S Rasmussen; Robert M Genta
Journal:  Clin Gastroenterol Hepatol       Date:  2021-06-02       Impact factor: 11.382

7.  Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Authors:  Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg
Journal:  Annu Rev Immunol       Date:  2021-03-01       Impact factor: 28.527

8.  Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field.

Authors:  Marc E Rothenberg; Shawna K B Hottinger; Nirmala Gonsalves; Glenn T Furuta; Margaret H Collins; Nicholas J Talley; Kathryn Peterson; Calies Menard-Katcher; Macie Smith; Ikuo Hirano; Robert M Genta; Mirna Chehade; Sandeep K Gupta; Jonathan M Spergel; Seema S Aceves; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2021-12-22       Impact factor: 10.793

9.  Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases.

Authors:  Craig C Reed; Corey J Ketchem; Talya L Miller; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2021-05-28       Impact factor: 11.382

10.  Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis.

Authors:  Erica J Brenner; Sydney B Greenberg; Nicole C Chang; S Ryanne Corder; Ellen L Cowherd; Evan S Dellon
Journal:  Clin Res Hepatol Gastroenterol       Date:  2021-06-25       Impact factor: 3.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.